Search Results - "A. Gherli"

P336: A CHEMOTRANSCRIPTOMIC SCREENING IDENTIFIES THE REVERSAL OF GLUCOCORTICOID RESISTANCE IN NOTCH1 MUTATED T‐ALL by Pagliaro, L., Moron Dalla Tor, L., Federica, V., Andrei, P., Monica, L., Kleissle, S., Neuenschwander, M., Gherli, A., Cerretani, E., D'Antuono, A., Simoncini, E., Montanaro, A., Roti, G.

Get full text

Blockade of oncogenic notch1 with the new serca inhibitor cad204520 in t-cell acute lymphoblastic leukemia by M. Marchesini, A. Gherli, A. Montanaro, C. Sorrentino, L. Pagliaro, C. Rompietti, S. Kitara, F. Rizzi, D. Stilli, R. La Starza, C. Mecucci, K. Stegmaier, A.M. Lund Winter, P. Sportoletti, M. Bublitz, W. Dalby-Brown, G. Roti

“…The discovery of the P-type ATPase Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) as a bidirectional modulator of oncogenic NOTCH1 suggests an innovative…”
Get full text

PF158 TARGETING ONCOGENIC NOTCH1 IN T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A NEW SELECTIVE SERCA INHIBITOR CAD204520 by Marchesini, M., Gherli, A., Winter, A.‐M. Lund, Patrizi, L., Kitara, S., Montanaro, A., Rompietti, C., Sorrentino, C., Stilli, D., Rizzi, F., Loiacono, C., Pagliaro, L., La Starza, R., Mecucci, C., Aversa, F., Sportoletti, P., Dalby‐Brown, W., Roti, G.

“…Background: Several studies support the development of NOTCH1 inhibitors for targeted cancer therapy. This idea is most compelling for T‐cell acute…”
Get full text